2022年12月23日

1847控股的全资子公司,公司签署协议,收购ICU眼镜控股公司,场外的设计师,非处方药阅读眼镜,太阳镜,蓝色的遮光眼镜,太阳读者,和户外专业太阳镜。收购将资金而发行的普通股或稀释股权,并将最终在2023年第一季度,惯例成交条件。ICU成立于1956年,总部设在霍利斯特,CA。公司拥有十个品牌”超过3000 sku在放大镜,太阳镜,和健康和个人护理领域。”其客户群包括范围广泛的国家、地区和专业零售商超过“7500个零售点。“ICU分布在所有的零售渠道,包括食品,特产,办公用品、制药、和户外运动商店。根据Statista,美国眼镜市场价值为293.8亿美元,预计2022年增长4.59%的复合年增长率从2021年到2027年,主要是由于视力障碍的增加和日益流行的时尚眼镜千禧一代。眼镜市场的场外交易市场,ICU参与,关注非处方太阳镜和老花镜和代表总数的12%或52亿美元的市场。首席执行官埃勒里·w·罗伯茨1847年,评论说:“加护病房是一个很好的我们的增长和现金流组合积极的公司。ICU发展高利润的和可持续的商业模式与固体金融类股,积极的息税前利润和毛利率约为40%。ICU的独特的眼镜为自己赢得了1号的标题提供者场外眼镜的目标,以及个人护理产品的独家供应商。ICU计划扩大其产品新客户的目标是在15000年到2025年零售店。 Its 50,000-square-foot facility has the capacity to ship up to 15 million units per year across an array of product categories and room for additional staff and warehousing to support at least double the company’s current revenue. “This transaction is another example of our successful acquisition strategy, targeting accretive and cash flow-positive companies. Our ability to acquire these businesses at attractive multiples, with minimum dilution to shareholders, has enabled us to offer shareholders a meaningful cash dividend. We look forward to working with ICU’s strong and talented team that has driven profitability and built an operational infrastructure to support significant growth,” concluded Roberts. Total consideration for the acquisition is $4.5 million, subject to adjustment, consisting of $4,000,000 in cash and unsecured subordinated promissory notes in the principal amount of $500,000. Share: